Diastolic Blood Pressure and Cognitive Functioning: Differences by Systolic Blood Pressure Among US Adults

Abstract

Background

The role of diastolic blood pressure (DBP) with cognitive functioning is under-explored in relation to levels of systolic blood pressure (SBP).

Methods

We studied 5466 participants from the National Health and Nutrition Examination Survey. Blood pressure was measured 3 times manually with a standardized sphygmomanometer and averaged. Cognitive functioning was measured using the digit symbol substitution test (DSST).

Results

Participants were 60 years or older, 55% female, and 81% non-Hispanic White. Most participants had a DBP between 70 to <80 mmHg (33.7%), between 60 to <70 mmHg (29.3%), or <60 mmHg (18.8%). From multivariable linear regression analyses, each 5 mmHg increment of DBP was associated with significantly higher DSST scores among individuals with SBP <120 only (ß: 0.56, 95% CI: 0.09, 1.03).

Conclusions

Among older US adults, at non-elevated levels of SBP, higher DBP is associated with better cognitive performance.

Keywords

blood pressure diastolic blood pressure cognition executive function older adults

Introduction

Elevated blood pressure (BP) or hypertension is a major risk factor for brain pathologies including stroke, vascular dementia, and its precursor, cognitive impairment.¹ Likewise, hypertension and elevated systolic BP (SBP) in particular, have been consistently associated with poor cognitive functioning^2,3 as well as cognitive decline,⁴ and subsequent dementia⁵ in observational studies. These results have even been supported by SPRINT-MIND, a randomized clinical trial which showed that intensive hypertension control reduced the risk of mild cognitive impairment (MCI) among individuals 50 years and older.⁶

While such studies find a clear relationship between elevated SBP and adverse brain health, the relationship between diastolic BP (DBP) and cognition is not as defined, with mixed findings.^7,8 For example, in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, higher DBP is associated with increased odds of cognitive impairment.⁷ On the other hand, higher DBP, particularly in older age⁹ has also been shown to be associated with better cognitive outcomes.⁸ It has been posited that such mixed findings can be attributed in part to differential associations by age and possibly sex. For example, higher DBP has been shown to be negatively associated with cognition during mid-life,^10,11 but positively associated with cognition in the later decades of life.¹² Indeed, findings from the Atherosclerosis Risk in Communities (ARIC) Study¹² have showed that lower DBP from mid to late life are associated with cognitive decline later in life. Further, results from the Norwegian Tromsø study showed that the relationship between DBP and cognition differs by sex, with higher DBP associated with lower cognitive function in men aged 45-55 years, but greater cognitive functioning among men aged 65-74 and with no associations among women.¹¹

Most studies have focused on either SBP or DBP as distinct exposures. Seldom is the relationship between SBP and cognition contextualized according to DBP (or vice versa). Though pulse pressure (PP), or the difference between SBP and DBP, is inversely related to cognitive functioning,^13,14 it does not account for clinically relevant thresholds of SBP and DBP.¹⁵ Thus, we sought to address this knowledge gap. Specifically, the objectives of the current study are to: (1) determine whether the association between SBP and cognition remains constant across all levels of DBP, (2) determine whether the association between DBP and cognition remains constant across all levels of SBP, and (3) determine whether these associations are modified by age or sex. To do so we leveraged data from the National Health and Nutrition Examination Survey (NHANES).

Methods

Study Sample

NHANES is a nationally representative, cross-sectional survey designed to evaluate the health and nutritional status of adults and children within the United States (US).¹⁶ This survey has operated on a continual basis since 1999, collecting data from household interviews and through physical examinations. The current analysis includes data from NHANES survey cycles (1999-2002 and 2011-2014) which consisted of a cognitive assessment in 5480 adults aged 60 or older. The National Center for Health Statistics approved all protocols and received informed consent from all participants prior to commencement.

Blood Pressure

BP was measured during the physical examination. After a five-minute rest period, using standardized sphygmomanometers, trained study staff obtained 3 to 4 BP measurements from each participant’s upper right arm while seated in an upright position. Cuff sizes were appropriately selected based on the arm circumference. The first 3 BP measurements were averaged. SBP was defined both continuously and categorized according to clinically relevant thresholds: <120 mmHg, 120 to 129 mmHg, 130 to 139 mmHg, 140 to 159 mmHg, and ≥160 mmHg. Similarly, DBP was also treated both as a continuous variable and categorized according to the following clinically relevant thresholds: <60, 60 to 69, 70 to 79, 80 to 89, and ≥90 mmHg.¹⁷

Cognitive Functioning

Cognitive functioning was measured using the Digit Symbol Substitution Test (DSST), a measure of executive functioning and processing speed.¹⁸ In this timed paper and pencil test, participants were tasked with correctly assigning symbols to their corresponding numbers based on a key that was provided. Scoring for DSST allows 1 point per correctly matched pair in the allotted time, with higher scores indicative of better cognitive function (range 0-133).¹⁹

Other Variables

Demographic information was collected during the NHANES interview portion of the survey. Age, sex, race/ethnicity, marital status, health insurance status, education level (less than high school, high school graduate, some college, college graduate), and annual income range (less than $55,000, more than $55,000) were self-reported. Individuals also self-reported information regarding health behaviors such as alcohol consumption (number of days alcohol consumed in 1 month), overall health status (poor, fair, good, very good, excellent), level of physical activity (time spent in a given day and week, intensity of activity, type of activity), current smoking status, use of BP medication, self-reported diabetes diagnosis, and use of diabetic medication.²⁰ Total cholesterol (mg/dL) and plasma glucose (mg/dL) was measured from a fasting blood draw following standard procedures.²¹ Consistent with guidelines in place at the time of data collection, hypertension was defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure as: self-reported use of BP medication, average measured SBP ≥ 140 mmHg, or average measured DBP ≥ 90 mmHg.²² Diabetes status was defined as meeting any of the following criteria: self-reported diabetes, diabetes medication use, or fasting plasma glucose levels ≥126 mg/dL.²³ Body mass index (BMI) was calculated from measured weight/measured height (kg/m²). Using BMI, individuals were categorized as: obese (BMI ≥30 kg/m²), overweight (BMI 25 to 29.9 kg/m²), normal weight (BMI 18.5 to 24.9 kg/m²), or underweight (BMI <18.5 kg/m²).²⁴

Statistical Analysis

We described demographic, clinical, and behavioral characteristics of the study population overall and according to categories of SBP. Then, we determined whether characteristics differed according to SBP category using means for continuous variables or chi-square tests for proportions. We also graphed the distribution of DBP category overall and according to category of SBP. To determine whether BP was associated with cognitive functioning, we used linear regression models. We tested the interaction between DBP and SBP categories and also between SBP and DBP categories with cognition. Interactions were significant (P < .05), leading to stratified models. We used a series of 4 linear regression models for each predictor of interest (DBP; modeling 5-unit increments and SBP; modeling 10mmHg increments) with DSST score. Model 1 was adjusted for sociodemographic characteristics (age, sex, and race). Model 2 included model 1 adjustments in addition to socio-economic factors (education, income, marital and insurance status). Model 3 included model 2 adjustments in addition to behavioral factors (alcohol use, health status, smoking status, and physical activity level). Model 4 included all model 3 adjustments in addition to clinical factors (BMI, diabetes, BP medication use, and total cholesterol). We also tested the three-way interaction of SBP and DBP with either sex, race, or education but, P values were all >.05. Finally, in a sensitivity analysis we repeated our main models among individuals with at least a high school education. All analyses were conducted using SUDAAN V11.0.3, utilized survey weights, and accounted for the complex survey design of NHANES.

Results

Among US adults aged 60 and older, 49.0% were aged 60-69 years, 34.0% were aged 70-79 years, and 17.0% were 80 years or older (Table 1). Over half (55.3%) were women, 81.3% were white, 7.6% were black, 7.1% were hispanic, 21.6% had less than a high school education, 57.4% had a household income < $55,000, 61.4% were married, and 94.9% had health insurance. Most (64.9%) had hypertension, about half (48.5%) reported use of BP-lowering medication, and 20.6% had diabetes. Mean BMI was 28.7 kg/m² and mean total cholesterol was 201.1 mg/dL. Characteristics differed by level of SBP such that those with higher SBP were more likely to be older, women, of Black race, have less than a HS education, have lower income, and participate in less physicial activity (P-values <.05).

Table 1.

Characteristics of the Study Sample overall and according to Systolic Blood Pressure.

	Overall N = 5466		SBP <120 N = 1171 (23.4%)		SBP 120-129 N = 1016 (20.0%)		SBP 130-139 N = 1133 (20.5%)		SBP 140-159 N = 1362 (23.9%)		SBP ≥160 N = 784 (12.2%)
Characteristic	%	SE	%	SE	%	SE	%	SE	%	SE	%	SE
Age^a
60-69	49.0%	1.1	56.6%	1.9	56.6%	2.3	51.4%	2.3	41.9%	1.9	31.6%	2.7
70-79	34.0%	.9	31.2%	1.8	31.7%	2.0	34.4%	1.8	38.5%	1.7	33.8%	2.5
80+	17.0%	.8	12.2%	1.3	11.7%	1.0	14.3%	1.4	19.6%	1.4	34.7%	2.3
Female^a	55.3%	.7	49.3%	1.7	53.8%	1.8	51.2%	2.0	57.9%	1.6	71.1%	1.9
Race/Ethnicity^a
White	81.3%	1.3	84.2%	1.3	82.7%	1.3	80.9%	1.7	79.8%	1.8	76.8%	2.9
Black	7.6%	.8	5.7%	.7	6.6%	0.8	8.3%	1.1	8.4%	1.1	10.5%	1.7
Hispanic	7.1%	1.0	6.6%	1.0	6.1%	.9	6.9%	1.0	7.4%	1.3	9.7%	2.1
Other	4.0%	.5	3.5%	.6	4.6%	0.8	4.0%	.6	4.3%	.7	3.1%	.5
Education^a
< High School	21.6%	1.1	18.1%	1.4	19.5%	1.6	22.1%	2.0	22.2%	1.5	29.8%	2.2
HS Grad	25.2%	1.0	21.8%	1.6	25.5%	1.8	24.1%	2.0	27.7%	1.5	28.2%	2.2
Some College	27.3%	1.0	28.2%	2.0	28.5%	2.1	26.2%	1.8	26.8%	1.5	26.7%	2.6
College Grad+	25.8%	1.3	31.9%	2.1	26.6%	2.5	27.5%	1.9	23.0%	1.7	15.2%	1.9
Income^a
< $55k	57.4%	1.7	53.6%	2.8	53.6%	2.2	56.7%	2.7	59.0%	2.5	68.6%	2.4
$55k+	33.7%	1.5	37.3%	2.5	38.2%	2.1	34.9%	2.8	31.8%	2.1	21.2%	2.1
Married^a	61.4%	.9	61.1%	1.5	65.5%	1.7	64.7%	2.0	61.1%	2.0	50.6%	2.3
Insured	94.9%	0.5	94.1%	1.0	95.2%	0.8	94.5%	1.0	95.3%	.7	95.4%	.9
Alcohol Use^a	66.4%	1.3	71.6%	1.7	68.8%	2.1	70.4%	2.0	64.1%	2.0	50.3%	2.5
Fair/Poor Health	21.4%	.9	21.4%	1.7	53.6%	1.6	56.7%	1.5	59.0%	1.2	68.6%	2.4
Physical Activity^a
None	52.5%	1.2	48.6%	2.2	52.3%	2.5	53.3%	2.0	53.2%	1.7	57.8%	2.5
Moderate	33.3%	1.0	34.8%	1.6	32.8%	2.1	32.1%	1.9	33.6%	1.6	32.8%	2.3
High	14.1%	1.0	16.6%	1.5	14.9%	1.7	14.5%	1.7	13.1%	1.3	9.4%	1.1
Current Smoker^a	11.3%	0.6	13.9%	1.2	11.7%	1.4	10.3%	1.3	10.9%	1.1	8.4%	1.2
BP Medication^a	48.5%	1.1	39.1%	2.0	47.0%	2.2	47.9%	1.9	55.0%	1.8	57.2%	2.6
Hypertension^a	64.9%	1.0	39.1%	2.0	47.5%	2.3	49.3%	1.9	100%	0.0	100%	0.0
Diabetes^a	20.6%	.7	17.8%	1.4	19.2%	1.6	24.0%	1.4	22.5%	1.2	18.8%	1.6
BMI, Mean^a	28.7	.1	28.4	.2	28.9	.3	29.4	.2	28.5	.3	28.1	.3
Cholesterol, Mean^a	201.1	.9	193.9	1.4	196.2	1.5	203.0	2.0	204.4	1.9	214.0	2.2

^aIndicates characteristic differs significantly (P < .05) by SBP category (chi-square tests for categorical variables and ANOVAs for means).

Abbreviations: BMI: Body Mass Index; BP: Blood Pressure HS: High School; SBP: Systolic blood pressure.

The distribution of DBP category overall and according to categories of SBP are presented in Figure 1. Overall, 18.8% had DBP <60 mmHg (95% CI: 17.2% - 20.6%), 29.3% had DBP between 60-70 mmHg (95% CI: 27.7% - 31.1%), 33.7% had DBP between 70-79 mmHg (95% CI: 31.8% - 35.6%), 13.8% had DBP between 80-89 mmHg (95% CI: 12.6% - 15.2%), and 4.3% had DBP ≥90 mmHg (95% CI: 3.4% - 5.3%). The distribution of DBP differed according to SBP category (p for interaction <.05). For example, among individuals with SBP <120 mmHg, 30.6% (95% CI: 26.6% - 35.0%) had DBP <60 mmHg and 0% had DBP ≥90 mmHg. In contrast, among individuals with SBP >160 mmHg, 14.1% (95% CI: 11.1% - 17.8%) had DBP <60 mmHg and 18.1% (95% CI: 13.6% - 23.6%) had DBP ≥90 mmHg.

Figure 1.

Distribution of DBP among US adults age 60 and older, stratified by SBP. Abbreviations DBP: Diastolic blood pressure; SBP: Systolic blood pressure there are no individuals SBP <120 mmHg and DBP ≥90 mmHg.

The interaction between DBP with SBP was significant (p for interaction <.05) and as a result, all analyses were stratified (Table 2). Mean DSST score in the sample was 49.8 (95% CI: 48.9, 50.7). In models adjusted for age, sex, and race only (model 1), every 5 mmHg increment of DBP was associated with higher DSST by: 1.34 units (95% CI: 0.80, 1.89) among individuals with SBP <120 mmHg, .79 units (95% CI: .27, 1.31) among individuals with SBP 130-<140 mmHg, and .54 units (95% CI: .09, 1.00) among individuals with SBP 140-<160 mmHg. Results were not significant among those with SBP 120-<130 mmHg (ß: 0.41, 95% CI: −.24, 1.05) or SBP ≥160 mmHg (ß: .15, 95% CI: −.36, .67). In fully adjusted models (model 4), results were significant at non-elevated levels of SBP (SBP <120 mmHg): each 5 mmHg increment in DBP was associated with a higher DSST score by .56 units (95% CI: .09, 1.03). Results from the sensitivity analysis restricted to individuals with at least a high school education were consistent showing that from fully adjusted models, each 5 mmHg increment in DBP was associated with a higher DSST score by .76 units (95% CI: .28, 1.23) only at SBP <120 mmHg.

Table 2.

Associations Between Diastolic Blood Pressure (DBP) and Digit Symbol Substitution Test (DSST), Overall and According to Categories Of Systolic Blood Pressure (SBP).

	Stratified by Systolic Blood Pressure
	Overall	SBP <120	SBP 120-129	SBP 130-139	SBP 140-159	SBP ≥160
	Beta (95% CI)	Beta (95% CI)	Beta (95% CI)	Beta (95% CI)	Beta (95% CI)	Beta (95% CI)
DBP (5 mmHg increment)
Model 1	.32 ^a (.08, .56)	1.34 ^a (.80, 1.89)	.41 (−.24, 1.05)	.79 ^a (.27, 1.31)	.54 ^a (.09, 1.00)	.15 (−.36, .67)
Model 2	.19 (−.02, .41)	.99 ^a (.46, 1.53)	.23 (−.37, .82)	.56 ^a (.18, .94)	.35 (−.03, .73)	−.08 (−.53, .37)
Model 3	.10 (−.11, .31)	.66 ^a (.17, 1.14)	.13 (−.43, .68)	.36 (−.05, .77)	.26 (−.09, .60)	−.08 (−.53, .37)
Model 4	.08 (−.14, .30)	.56 ^a (.09, 1.03)	−.03 (−.58, .52)	.35 (−.04, .75)	.26 (−.08, .61)	−.07 (−.49, .36)

^aIndicates estimate is significant (P < .05).

Model 1 is adjusted for age, sex, and race/ethnicity. Model 2 is adjusted for model 1 covariates in addition to: education, income, marital status, and health insurance. Model 3 is adjusted for model 2 covariates in addition to: alcohol use, smoking, physical activity, and self-rated general health. Model 4 is adjusted for model 3 covariates in addition to blood pressure medication, body mass index, diabetes, and total cholesterol.

Figure 2 displays the associations between SBP and cognitive functioning stratified by categories of DBP. In fully adjusted models, every 10 mmHg increment in SBP was associated with lower DSST by: −.88 units (95% CI: −1.31, −.45) among participants with DBP 60-<70 mmHg, −.57 units (95% CI: −.93, −.21) among participants with DBP 70-<80 mmHg, and −.98 units (95% CI: −1.80, −.17) among participants with DBP 80-<90 mmHg. Results were not significant among individuals with DBP <60 mmHg (ß: −.45, 95% CI: −.91, .02) or DBP >90 mmHg (ß: −.67, 95% CI: −1.78, .44). Results from the sensitivity analysis restricted to individuals with at least a high school education (not shown) were consistent showing every 10 mmHg increment in SBP was associated with lower DSST score by: −1.01 (95% CI: −1.57, −.46) at DBP 60-<70 mmHg, −.59 (95% CI: −1.08, −.09) at DBP 70- <79 mmHg, and −1.04 (95% CI: −2.05, −.03) at DBP 70-<80 mmHg.

Figure 2.

Association between SBP and DSST, overall and according to categories of DBP. Abbreviations DBP: Diastolic blood pressure; DSST: Digit Symbol Substitution Test; SBP: Systolic blood pressure. *Indicates estimate is significant (P < .05) Models are adjusted for age, sex, race/ethnicity, education, income, marital status, health insurance, alcohol use, smoking, physical activity, self-rated general health, blood pressure medication, body mass index, diabetes, and total cholesterol.

Discussion

In a population-based study representative of non-institutionalized US adults aged 60 and older, higher DBP was associated with better executive functioning at non-elevated levels of SBP (<120 mmHg). At elevated SBP, there was no association between DBP and cognitive functioning. On the other hand, higher SBP at any level of DBP was associated with lower executive functioning. These results highlight the importance of healthy SBP for brain health and emphasize the need for contextualization of SBP in consideration of DBP as a risk factor for cognitive functioning.

In US cohorts, the relationship between DBP and cognitive functioning has been mixed. Findings from the Coronary Artery Risk Development in Young Adults (CARDIA) study showed that higher cumulative DBP in young adulthood to mid-life are associated with lower cognitive performance in midlife.²⁵ Among participants of the Multi-Ethnic Study of Atherosclerosis (MESA) aged 45-84, higher baseline DBP was associated with lower scores on multiple domains of cognitive functioning.²⁶ Likewise, among diverse US Hispanics/Latino participants of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), aged 45-74, each 10 mmHg increment of DBP was associated with .04 standard deviation lower executive functioning.¹⁴ These findings showing an inverse association between DBP and cognition have also been corroborated in international cohorts. In a prospective cohort of 12,281 older adults (median age 81) in China, every 10 mmHg increment of DBP was associated with a 6% increased risk of cognitive impairment measured from the Mini Mental State Exam.²⁷ In contrast, other research,^12,13 including the current study, has shown positive associations between DBP and executive functioning. This is particularly true among older cohorts.²⁸ In the ARIC Neurocognitive study, lower (<68 mmHg) vs higher (>76 mmHg) DBP from mid-life to later life was associated with cognitive decline later in life.¹² Similarly, findings from the US Health and Retirement Study (HRS) and U.K. English Longitudinal Study of Ageing (ELSA), also showed that among adults aged 50 and over, higher cumulative DBP exposure is associated with decelerated cognitive decline.¹³

Though age at BP assessment (mid-life or late-life) may certainly account for the discrepant findings, we posit that other factors may be contributing to the mixed results. In our study we found a significant interaction between DBP and SBP with cognitive functioning. DBP was associated with better cognitive functioning only at non-elevated levels of SBP. These results may indicate that greater DBP protects against cerebral hypoperfusion²⁹ resulting in better cognitive performance. Had we considered only main effects (overall models), our associations would have been null. Our findings support the need for a more nuanced and thorough approach when examining DBP in relation to cognition. Indeed, most studies showing relationships between higher DBP and better cognitive performance are specific to sub-populations (i.e. older adults).²⁸ Yet, there is limited research which examines DBP in the context of SBP (or vice versa). While pulse pressure (PP), or the difference between SBP and DBP, is inversely associated with cognitive functioning,³⁰ it does not account for clinically relevant BP thresholds. A PP that is less than 25% SBP is considered to be narrowed and a PP that is greater than 100 mmHg is considered to be widened.³¹ Thus, the current study may help to contextualize many of the findings with respect to PP: higher DBP at non-elevated SBP (consistent with low PP) is associated with better cognitive performance. High SBP and low DBP, indicative of high PP, can be mechanistically attributed to impaired cognitive functioning for various reasons. Aging is associated with a number of vascular changes.³² As a result of enduring pulsation with arterial blood, the vasculature, particularly that of the large vessels including the aorta, undergo calcification, endothelial dysfunction, luminal enlargement, and thickening of the vessel wall.³³ These changes are characteristic of arterial stiffness and result in greater pulse wave velocity, higher SBP, and consequently, greater PP.³² In addition to aging, another well-known determinant of arterial stiffness is longstanding hypertension.³⁴ Arterial stiffness and resultant lowered arterial compliance plays a pivotal role in the lowering of DBP after age 60,³⁵ further leading to greater PP. Persistently high PP of this nature would impair cerebral blood flow and thereby cognitive functioning, as seen in numerous studies.^13,14,36 In turn, arterial stiffness has emerged as a recognized independent risk factor for cognitive decline,³⁷ dementia,³⁸ and stroke.³⁹

Though the main focus of our study was on DBP, consistent with the literature, we also found SBP inversely associated with cognitive functioning. For example, data from ARIC,¹² CARDIA,²⁵ MESA,²⁶ the Northern Manhattan Study (NOMAS),⁴⁰ and HCHS/SOL¹⁴ consistently show high SBP associated with lower cognitive functioning and cognitive decline. These findings are even supported by randomized controlled trial data. In the SPRINT-Memory and Cognition in Decreased Hypertension (MIND) study, intensive SBP control (to a goal of <120 mmHg) was associated with decreased cognitive impairment compared to those treated to a standard goal of <140 mmHg.⁶ Our findings, though cross-sectional, corroborate these results, and show clear inverse associations between SBP and cognitive functioning at all levels of DBP.

The current study is not without limitations. First, our data are cross-sectional, limiting any causal inference. Further, our study utilized only one measure of cognitive function (DSST to measure executive functioning/processing speed).¹⁸ Though we acknowledge that analysis of different cognitive domains may be warranted, we emphasize that the DSST has been shown to serve as a marker for cognitive ability in learning associations and to be predictive of future clinical as well as subclinical disorders of cognition.^18,19 In addition, while the study sample size was large, we were underpowered to detect a 3 way interaction between SBP, DBP, with sex, education, or age. Given prior literature demonstrating the importance of both age and education as potential moderating factors,⁴¹ we believe this is an important next step. Finally, given the design of our study, we could not adequately account for sub-clinical neuro-degenerative diseases which influence cognitive capabilities. Likewise, though DSST is a measure of executive functioning,¹⁸ it can be sensitive to other impairments (e.g. non-essential tremors and arthritis). Therefore, it is important to consider that lower DSST results may be due to non-cognitive related deficits. Despite these limitations, our study has notable strengths. First, our study population is representative of US adults as a whole and includes diverse racial/ethnic groups. Standardized measures were utilized to obtain BP and cognitive functioning. While the role of hypertension in general and isolated systolic hypertension on cognition is clear, the relationship between DBP and cognition warrants more attention. This study employed a novel approach in elucidating the relationship between BP and cognition, focusing on the interaction between DBP and SBP. Our findings can help guide future research in this area and have implications for the clinical management of hypertension. Specifically, the efficacy of lowering DBP among older adults with isolated diastolic hypertension remains unknown as observational and clinical studies have reported mixed results.⁴² Our findings suggest that isolated diastolic hypertension in older adults may not be associated with adverse cognitive outcomes.

In summary, in a representative study of older US adults, higher DBP was associated with better cognitive performance at non-elevated levels of SBP only. Higher SBP, at any level of DBP, was associated with worse cognitive performance. These findings emphasize that blood pressure is a potent vascular risk factor associated with cognitive functioning. To fully elucidate associations between BP with cognition, both SBP and DBP need to be considered in proper context in relation to one another. Further studies are warranted to corroborate these findings using longitudinal data.

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr. Elfassy is supported by NIH/NIMHD (K01MD014158).

ORCID iD

T Elfassy

References

Faraco

Iadecola

. Hypertension: A harbinger of stroke and dementia. Hypertension. 2013;62(5):810-817. doi:10.1161/HYPERTENSIONAHA.113.01063

Manolio

Olson

Longstreth

. Hypertension and cognitive function: Pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep. 2003;5(3):255-261. doi:10.1007/s11906-003-0029-6

Iadecola

Yaffe

Biller

, et al. Impact of hypertension on cognitive function: A scientific statement from the american heart association. Hypertension. 2016;68(6):e67-e94. doi:10.1161/HYP.0000000000000053

Yaffe

Vittinghoff

Hoang

Matthews

Golden

Zeki Al Hazzouri

. Cardiovascular risk factors across the life course and cognitive decline: A pooled cohort study. Neurology. 2021;96(17):e2212-e2219. doi:10.1212/WNL.0000000000011747

Kivipelto

Helkala

E-L

Laakso

, et al. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. Bmj. 2001;322(7300):1447-1451. doi:10.1136/bmj.322.7300.1447

SPRINT MIND Investigators for the SPRINT Research Group, Williamson

Pajewski

, et al. Effect of intensive vs standard blood pressure control on probable dementia: A randomized clinical trial. JAMA. 2019;321(6):553-561. doi:10.1001/jama.2018.21442

Tsivgoulis

Alexandrov

Wadley

, et al. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology. 2009;73(8):589-595. doi:10.1212/WNL.0b013e3181b38969

Pandav

Dodge

DeKosky

Ganguli

. Blood pressure and cognitive impairment in India and the United States: A cross-national epidemiological study. Arch Neurol. 2003;60(8):1123-1128. doi:10.1001/archneur.60.8.1123

Muller

Sigurdsson

Kjartansson

, et al. Joint effect of mid- and late-life blood pressure on the brain: The AGES-Reykjavik study. Neurology. 2014;82(24):2187-2195. doi:10.1212/WNL.0000000000000517

10.

Kilander

Nyman

Boberg

Hansson

Lithell

. Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension. 1998;31(3):780-786. doi:10.1161/01.hyp.31.3.780

11.

Hestad

Engedal

Schirmer

Strand

. The effect of blood pressure on cognitive performance. An 8-year follow-up of the Tromsø Study, comprising people aged 45–74 Years. Front Psychol. 2020;11:607. doi:10.3389/fpsyg.2020.00607

12.

Yano

Griswold

Wang

, et al. Long-term blood pressure level and variability from midlife to later life and subsequent cognitive change: The aric neurocognitive study. J Am Heart Assoc. 2018;7(15):e009578. doi:10.1161/JAHA.118.009578

13.

Zhu

Hua

Zhong

Xie

. Association of cumulative blood pressure with cognitive decline, dementia, and mortality. J Am Coll Cardiol. 2022;79(14):1321-1335. doi:10.1016/j.jacc.2022.01.045

14.

Tarraf

Rodríguez

Daviglus

, et al. Blood pressure and hispanic/latino cognitive function: Hispanic community health study/study of latinos results. J Alzheimers Dis. 2017;59(1):31-42. doi:10.3233/JAD-170017

15.

Whelton

Carey

Aronow

, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the american college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269-1324. doi:10.1161/HYP.0000000000000066

16.

Centers for Disease Control and Prevention (CDC) . National health and nutrition examination survey data. In: (NCHS) NCfHS. Hyattsville, MD: U.S. Department of Health and Human Services; 2022.

17.

Shrout

Rudy

Piascik

. Hypertension update, JNC8 and beyond. Curr Opin Pharmacol. 2017;33:41-46. doi:10.1016/j.coph.2017.03.004

18.

Jaeger

. Digit symbol substitution test: The case for sensitivity over specificity in neuropsychological testing. J Clin Psychopharmacol. 2018;38(5):513-519. doi:10.1097/JCP.0000000000000941

19.

Rosano

Perera

Inzitari

Newman

Longstreth

Studenski

. Digit symbol substitution test and future clinical and subclinical disorders of cognition, mobility and mood in older adults. Age Ageing. 2016;45(5):688-695. doi:10.1093/ageing/afw116

20.

Centers for Disease Control and Prevention (CDC) . National health and nutrition examination survey 2011-2012 questionnaire data. In: (NCHS) NCfHS. Hyattsville, MD: U.S. Department of Health and Human Services; 2011.

21.

Centers for Disease Control and Prevention (CDC) . National health and nutrition examination survey 2011-2012 laboratory procedures manual. In: (NCHS) NCfHS. Hyattsville, MD: U.S. Department of Health and Human Services; 2011.

22.

Chobanian

Bakris

Black

, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206-1252. doi:10.1161/01.HYP.0000107251.49515.c2

23.

Keller

Bucher Della Torre

. Sugar-sweetened beverages and obesity among children and adolescents: A review of systematic literature reviews. Child Obes. 2015;11(4):338-346. doi:10.1089/chi.2014.0117

24.

Weir

Jan

25.

Mahinrad

Kurian

Garner

, et al. Cumulative blood pressure exposure during young adulthood and mobility and cognitive function in midlife. Circulation. 2020;141(9):712-724. doi:10.1161/CIRCULATIONAHA.119.042502

26.

Hughes

Craft

Baker

, et al. Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The multi-ethnic study of atherosclerosis. Alzheimers Dement (Amst). 2017;8:18-25. doi:10.1016/j.dadm.2017.03.003

27.

Yuan

J-Q

Y-B

Chen

H-S

, et al. Association between late-life blood pressure and the incidence of cognitive impairment: A community-based prospective cohort study. J Am Med Dir Assoc. 2019;20(2):177-182. doi:10.1016/j.jamda.2018.05.029

28.

Y-N

Tan

C-C

Shen

X-N

, et al. Blood pressure and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 209 prospective studies. Hypertension. 2020;76(1):217-225. doi:10.1161/HYPERTENSIONAHA.120.14993

29.

Warnert

Rodrigues

Burchell

, et al.

Is high blood pressure self-protection for the brain?

Circ Res. 2016;119(12):e140-e151. doi:10.1161/CIRCRESAHA.116.309493

30.

Obisesan

Martins

, et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the third national health and nutrition examination survey. J Am Geriatr Soc. 2008;56(3):501-509. doi:10.1111/j.1532-5415.2007.01592.x

31.

Homan

Bordes

Cichowski

32.

Lee

. Aging and arterial stiffness. Circ J. 2010;74(11):2257-2262. doi:10.1253/circj.cj-10-0910

33.

Wang

Ren

, et al. Age-related impairment of vascular structure and functions. Aging Dis. 2017;8(5):590-610. doi:10.14336/AD.2017.0430

34.

Laurent

Boutouyrie

. Arterial stiffness and hypertension in the elderly. Front Cardiovasc Med. 2020;7:544302. doi:10.3389/fcvm.2020.544302

35.

Hilden

. The influence of arterial compliance on diastolic blood pressure and its relation to cardiovascular events. J Hum Hypertens. 1991;5(3):131-135.

36.

Yasar

Nothelle

Mielke

Carlson

. Evaluation of the effect of systolic blood pressure and pulse pressure on cognitive function: The women's health and aging study II. PLoS One. 2011;6(12):e27976. doi:10.1371/journal.pone.0027976

37.

Pase

Herbert

Grima

Pipingas

O'Rourke

. Arterial stiffness as a cause of cognitive decline and dementia: A systematic review and meta-analysis. Intern Med J. 2012;42(7):808-815. doi:10.1111/j.1445-5994.2011.02645.x

38.

Hughes

Wagenknecht

Craft

, et al. Arterial stiffness and dementia pathology: Atherosclerosis risk in communities (Aric)-pet study. Neurology. 2018;90(14):e1248-e1256. doi:10.1212/WNL.0000000000005259

39.

Laurent

Katsahian

Fassot

, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34(5):1203-1206. doi:10.1161/01.STR.0000065428.03209.64

40.

Sun

Dong

Levin

, et al. Systolic blood pressure and cognition in the elderly: the northern manhattan study. J Alzheimers Dis. 2021;82(2):689-699. doi:10.3233/JAD-210252

41.

Alley

Suthers

Crimmins

. Education and cognitive decline in older americans: Results from the ahead sample. Res Aging. 2007;29(1):73-94. doi:10.1177/0164027506294245

42.

Yano

Chang Kim

Lee

, et al. Response to isolated diastolic hypertension and risk of cardiovascular disease: Controversies in hypertension - con side of the argument. Hypertension. 2022;79(8):1579. doi:10.1161/HYPERTENSIONAHA.122.19493